Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleVascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy.AuthorsBuchroithner J; Pichler J; Marosi C; Widhalm G; Seiz-Rosenhagen M; Novosielski M; Oberndorfer S; Ruckser R; Rössler K; Azizi A; von Campe G; Bordihn K; Felzmann TPublicationInternational journal of clinical pharmacology and therapeutics, 2014, Vol 52, Issue 1, p76ISSN0946-1965Publication typearticleDOI10.5414/CPXCES13EA02